Product Pathways - Metabolism
Insulin (C27C9) Rabbit mAb (Pacific Blue™ Conjugate) #8472
|8472S||100 µl (50 tests)||---||In Stock||---|
|8472||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|F||1:50||Human, Mouse, Rat||Endogenous||Rabbit IgG|
Species cross-reactivity is determined by western blot using the unconjugated antibody.
Applications Key: F=Flow Cytometry
Specificity / Sensitivity
Insulin (C27C9) Rabbit mAb (Pacific Blue™ Conjugate) detects endogenous levels of total insulin protein.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the sequence of human insulin.
This Cell Signaling Technology antibody is conjugated to Pacific Blue™ fluorescent dye and tested in-house for direct flow cytometry in human and mouse cells. The antibody is expected to exhibit the same species cross-reactivity as the unconjugated antibody Insulin (C27C9) Rabbit mAb #3014.
The maintenance of glucose homeostasis is an essential physiological process that is regulated by hormones. An elevation in blood glucose levels during feeding stimulates insulin release from pancreatic β cells through a glucose sensing pathway (1). Insulin is synthesized as a precursor molecule, proinsulin, which is processed prior to secretion. A- and B-peptides are joined together by a disulfide bond to form insulin, while the central portion of the precursor molecule is cleaved and released as the C-peptide. Insulin stimulates glucose uptake from blood into skeletal muscle and adipose tissue. Insulin deficiency leads to type 1 diabetes mellitus (2).
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Pacific Blue™ is a trademark of Molecular Probes, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
This antibody is developed, validated, and produced by CST using in part technology under license (granting certain rights including those under U.S. Patent No. 5,675,063) from Epitomics, Inc.